article thumbnail

Empowering scientists in the genomic revolution

sptlabtech

The field of genomics has witnessed a revolutionary transformation, leading to a better understanding of health and disease, as well the emergence of personalized medicine to improve therapeutic outcomes. Book your tailored demo

article thumbnail

From Academia to Patients: The Evolution of MSL Territories

H1 Blog

How to Create Optimal Territories with Key Opinion Leaders and Patient Demographics As the role of the Medical Science Liaison (MSL) has evolved from academic rigor to understanding disease trends, a key component of MSL territory planning is collaboration with Key Opinion Leaders (KOLs). But what happens when knowledge gaps exist?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

H1’s Predictions for Healthcare and Pharma in 2025

H1 Blog

Ariel Katz , CEO & Co-Founder AI will be used to combat rare diseases. In 2025, we will see AI leveraged for faster, more accurate diagnoses in rare disease cases, reducing the rate of more than a quarter of rare disease patients who spend 7+ years until they receive a correct diagnosis (up from 15% from 30 years ago).

article thumbnail

FDA Poised to Make Impact on Underrepresented Populations in Clinical Studies

H1 Blog

Increasing diversity in clinical trials not only makes the findings more relevant to various patient groups, but also enhances knowledge about the disease or medical product being studied. Find out more by requesting a demo today. I am thankful that the FDA is taking this step in the right direction for all of us.”H1

FDA 59
article thumbnail

Why Drug Approvals and Development Hinge on Diversity

H1 Blog

To learn more about how H1 can help diversify your HCP engagement strategy, request a demo. When planning a drug development program, it’s essential to consider the diversity of patient populations that will be recruited into clinical trials.

article thumbnail

A Holistic Approach to Measuring Impact

H1 Blog

Medical Affairs Strategies that Demonstrate and Improve Impact Medical Affairs plays an essential role in evidence-based medicine, disease education, and driving better outcomes. Request a demo today to learn more. Their knowledge is crucial as medications become more specialized and complex.

Science 59
article thumbnail

A Lesson in History: Assessing Trial Performance Data for Future Trial Design

H1 Blog

This is especially true for rare disease populations, where understanding the nuances between different patient cohorts is key to achieving positive outcomes. To learn more about how to leverage performance data in your trial planning, request a demo of H1’s Clinical Trial Intelligence solution – Trial Landscape. The Michael J.

Trials 52